Listed

Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2015

Filed with the SEC on May 14, 2015 and accepted by EDGAR at May 14, 2015, 16:13 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-01-01 to 2015-03-31$300.3kus-gaap:SalesRevenueNet
Cost of revenue3 months2015-01-01 to 2015-03-31$135.6kus-gaap:CostOfRevenue
Gross profit3 months2015-01-01 to 2015-03-31$164.7kus-gaap:GrossProfit
Operating income3 months2015-01-01 to 2015-03-31−$143.2kus-gaap:OperatingIncomeLoss
Interest expense3 months2015-01-01 to 2015-03-31−$1.7kus-gaap:InterestExpense
Net income3 months2015-01-01 to 2015-03-31−$144.9kus-gaap:NetIncomeLoss
Operating cash flow3 months2015-01-01 to 2015-03-31−$119.9kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2015-01-01 to 2015-03-31−$5.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-03-31$38.7kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-03-31$169.7kus-gaap:AssetsCurrent
Total assetsAt period end2015-03-31$194.0kus-gaap:Assets
Current liabilitiesAt period end2015-03-31$331.4kus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2015-03-31−$137.4kus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001211524-15-000055. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.